Trace analysis of fluoxetine and its metabolite norfluoxetine. Part I: Development of a chiral liquid chromatography-tandem mass spectrometry method for wastewater samples

Journal of Chromatography A

Volumn 1218, Issue 33, 2011, Pages 5587-5596

  Barclay, Victoria K H ^a   Tyrefors, Niklas L ^a,b   Johansson, I Monika ^a,c   Pettersson, Curt E ^a  

^a UPPSALA UNIVERSITY   (Sweden)

^b Oasmia Pharmaceutical AB   (Sweden)

^c MEDICAL PRODUCTS AGENCY   (Sweden)

Author keywords

Chiral LC MS MS; Fluoxetine; Isotope labeled compounds; Norfluoxetine; Solid phase extraction; Wastewater

Indexed keywords

FLUOXETINE; ISOTOPE-LABELED COMPOUNDS; LC-MS/MS; NORFLUOXETINE; SOLID PHASE EXTRACTION;

ACETONITRILE; AMMONIUM COMPOUNDS; CHIRALITY; ENANTIOMERS; EXTRACTION; ISOTOPES; LIQUID CHROMATOGRAPHY; LIQUIDS; MASS SPECTROMETRY; METABOLISM; METABOLITES; PH EFFECTS; TRACE ANALYSIS; WASTEWATER;

WASTEWATER TREATMENT;

ACETONITRILE; AMMONIUM ACETATE; FLUOXETINE; NORFLUOXETINE; OROSOMUCOID;

ARTICLE; CALIBRATION; CATION EXCHANGE; CHIRAL CHROMATOGRAPHY; CONTROLLED STUDY; DRUG STRUCTURE; EFFLUENT; ELUTION; ENANTIOMER; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HYDROPHOBICITY; ION EXCHANGE; ISOELECTRIC POINT; LIQUID CHROMATOGRAPHY; MOLECULAR INTERACTION; NONHUMAN; PH; PRIORITY JOURNAL; PROCESS OPTIMIZATION; SEPARATION TECHNIQUE; SOLID PHASE EXTRACTION; TANDEM MASS SPECTROMETRY; WASTE WATER;

ANTIDEPRESSIVE AGENTS; CHROMATOGRAPHY, LIQUID; FLUOXETINE; SEWAGE; TANDEM MASS SPECTROMETRY; WATER POLLUTANTS, CHEMICAL;

EID: 79960698777     PISSN: 00219673     EISSN: 18733778     Source Type: Journal    
DOI: 10.1016/j.chroma.2011.06.024     Document Type: Article

References (47)

1. Heberer T. Toxicol. Lett. 2002, 131:5.
2. Ternes T.A. Water Res. 1998, 32:3245.
3. Kolpin D.W., Furlong E.T., Meyer M.T., Thurman E.M., Zaugg S.D., Barber L.B., Buxton H.T. Environ. Sci. Technol. 2002, 36:1202.
4. Heberer T., Schmidt-Bäumler K., Stan H.-J. Acta Hydrochim. Hydrobiol. 1998, 26:272.
5. Vasskog T., Anderssen T., Pedersen-Bjergaard S., Kallenborn R., Jensen E. J. Chromatogr. A 2008, 1185:194.
6. Benotti M.J., Trenholm R.A., Vanderford B.J., Holady J.C., Stanford B.D., Snyder S.A. Environ. Sci. Technol. 2008, 43:597.
7. Wong C. Anal. Bioanal. Chem. 2006, 386:544.
8. Rang H.P., Dale M.M., Ritter J.M. Pharmacology 1999, Churchill Livingstone, Edinburgh. 4th ed.
9. Andrés F.D., Castañeda G., Ríos Á. Chirality 2009, 21:751.
10. Nakanishi T., Yamakawa N., Asahi T., Shibata N., Ohtani B., Osaka T. Chirality 2004, 16:S36.
11. Richardson S.D. Anal. Chem. 2009, 81:4645.
12. Kostopoulou M., Nikolaou A. TrAC-Trends Anal. Chem. 2008, 27:1023.
13. Richardson S.D. Anal. Chem. 2010, 82:4742.
14. Öllers S., Singer H.P., Fässler P., Müller S.R. J. Chromatogr. A 2001, 911:225.
15. Scordo M.G., Spina E., Dahl M.-L., Gatti G., Perucca E. Basic Clin. Pharmacol. Toxicol. 2005, 97:296.
16. A. Claesson, B. Danielsson, U. Svensson, Läkemedelskemi, 2nd ed., Apotekarsocieteten, Kristianstad, 1996.
17. Kohler H.-P.E., Angst W., Giger W., Kanz C., Müller S., Suter M.J.-F. Chimia 1997, 51:947.
18. Fono L.J., Sedlak D.L. Environ. Sci. Technol. 2005, 39:9244.
19. MacLeod S.L., Sudhir P., Wong C.S. J. Chromatogr. A 2007, 1170:23.
20. Ward T.J., Baker B.A. Anal. Chem. 2008, 80:4363.
21. Ghassempour A., Aboul-Enein H.Y. J. Chromatogr. A 2008, 1191:182.
22. Kaliszan R., Nasal A., Turowski M. Biomed. Chromatogr. 1995, 9:211.
23. Enquist M., Hermansson J. J. Chromatogr. 1990, 519:285.
24. Vandenbosch C., Massart D.L., Lindner W. J. Pharm. Biomed. Anal. 1992, 10:895.
25. Hermansson J., Hermansson I. J. Chromatogr. A 1994, 666:181.
26. Gyimesiné Forrás K. Acta Pharm. Hung. 2002, 72:205.
27. Lajeunesse A., Gagnon C., Sauveó S. Anal. Chem. 2008, 80:5325.
28. Gracia-Lor E., Sancho J.V., Hernández F. J. Chromatogr. A 2010, 1217:622.
29. Matuszewski B.K., Constanzer M.L., Chavez-Eng C.M. Anal. Chem. 2003, 75:3019.
30. International Conference on Harmonisation (ICH) of Technical Requirements for Registration of Pharmaceutical for Human Use, Validation of Analytical Procedures: Text and Methodology Q2(R1), Geneva, 2005.
31. Guidance for Industry Bioanalytical Method Validation 2001, US Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research (CDER), Center for Veterinary Medicine (CVM), Rockville.
32. Babić S., Mutavdžić Pavlović D., Ašperger D., Periša M., Zrnčić M., Horvat A., Kaštelan-Macan M. Anal. Bioanal. Chem. 2010, 398:1185.
33. van Nuijs A.L.N., Tarcomnicu I., Bervoets L., Blust R., Jorens P., Neels H., Covaci A. Anal. Bioanal. Chem. 2009, 395:819.
34. Schultz M.M., Furlong E.T. Anal. Chem. 2008, 80:1756.
35. Gros M., Petrovicó M., Barceloó D. Anal. Chem. 2008, 81:898.
36. Vieno N.M., Tuhkanen T., Kronberg L. J. Chromatogr. A 2006, 1134:101.
37. Van De Steene J.C., Lambert W.E. J. Chromatogr. A 2008, 1182:153.
38. Batt A.L., Kostich M.S., Lazorchak J.M. Anal. Chem. 2008, 80:5021.
39. Arvidsson E., Jansson S.O., Schill G. J. Chromatogr. 1992, 591:55.
40. Allenmark S. Chromatographic Enantioseparation: Methods and Applications 1991, Ellis Horwood Series in Analytical Chemistry, London. 2nd ed.
41. Xuan H., Hage D.S. J. Sep. Sci. 2006, 29:1412.
42. Vukmanic D., Chiba M. J. Chromatogr. 1989, 483:189.
43. Michishita T., Franco P., Zhang T. J. Sep. Sci. 2010, 33:3627.
44. Balmér K., Persson B.-A., Schill G. J. Chromatogr. 1989, 477:107.
45. Allenmark S., Bomgren B., Borén H. J. Chromatogr. 1984, 316:617.
46. Hjerten S. Methods Biochem. Anal. 1981, 27:89.
47. Hughes N.C., Wong E.Y.K., Fan J., Bajaj N. AAPS J. 2007, 9:E353.